Symbol
| SLC16A2
| contributors: mct - updated : 15-09-2021
|
HGNC name
| solute carrier family 16, member 2 (monocarboxylic acid transporter 8)
|
HGNC id
| 10923
|
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
miscelleaneous | thyroid | | |
DITPA, (an SLC16A2-independent TH analog) is a promising treatment for developmentally-regulated myelination in AHDS |
| | | |
| Mct8 knockout (ko) mice do not exhibit overt neurological symptoms but fully replicate the unusual serum TH profile with highly increased serum T3 in the presence of low serum T4 |